Owlet (OWLT) announced that the Central Drugs Standard Control Organization approved Dream Sock for distribution. This marks a significant milestone for the company as it now prepares to launch its integrated monitoring devices across India in early 2026. With approval from the CDSCO, India’s national regulatory body for cosmetics, pharmaceuticals, and medical devices, Owlet becomes one of the few infant health technology companies to meet the region’s medical device requirements.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OWLT: